VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,917,015 | -0.8% | 71,238 | +11.1% | 0.18% | +0.6% |
| Q2 2023 | $1,931,527 | +79.2% | 64,149 | +92.5% | 0.17% | +91.2% |
| Q1 2023 | $1,078,064 | +115.3% | 33,325 | +90.7% | 0.09% | +89.6% |
| Q4 2022 | $500,834 | +72.1% | 17,475 | +44.7% | 0.05% | +37.1% |
| Q3 2022 | $291,000 | +7.8% | 12,075 | +71.5% | 0.04% | +25.0% |
| Q1 2022 | $270,000 | +13400.0% | 7,040 | +6940.0% | 0.03% | – |
| Q3 2018 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | -60.0% | 100 | -50.0% | 0.00% | -100.0% |
| Q3 2017 | $5,000 | +150.0% | 200 | +100.0% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |